Institutional Ownership Pmv Pharmaceuticals, Inc. (PMVP)
This table provides information about the institutional ownership of Pmv Pharmaceuticals, Inc. (PMVP). We have compiled data on the 62 institutions that hold shares in the stock, with a total of 40.4 Million shares, which have been reported (via 13F filing form) to have a value of $54.1 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ci Private Wealth, LLC
Miami, FL |
May 14, 2025 Q1 2025 |
10,000
shares
|
$12,700
0.0% of portfolio
|
Q4 2023
New holding
|
|
Wells Fargo & Company
San Francisco, CA |
May 13, 2025 Q1 2025 |
10,000
shares
|
$12,700
0.0% of portfolio
|
Q1 2025
New holding
|
|
Cutler Group LP
|
Apr 19, 2024 Q1 2024 |
2,500
shares
|
$3,175
0.0% of portfolio
|
Q4 2023
Reduced 13.79%
|
|
Jones Financial Companies Lllp
|
May 28, 2025 Q1 2025 |
1,000
shares
|
$1,270
0.0% of portfolio
|
Q1 2025
Added 900.0%
|
|
Tower Research Capital LLC (Trc)
New York, NY |
May 15, 2025 Q1 2025 |
720
shares
|
$914
0.0% of portfolio
|
Q1 2025
Reduced 52.79%
|
|
Royal Bank Of Canada
Toronto, A6 |
May 15, 2025 Q1 2025 |
384
shares
|
$487
0.0% of portfolio
|
Q1 2025
Reduced 99.05%
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
318
shares
|
$403
0.0% of portfolio
|
Q3 2022
New holding
|
|
Four Thought Financial, LLC
Venice, FL |
Nov 21, 2022 Q3 2022 |
52
shares
|
$66
0.0% of portfolio
|
Q3 2022
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
May 14, 2025 Q1 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q1 2025
New holding
|